Antibodies |
|
FAP |
Abcam |
ab207178; RRID: AB_2864720 |
BMI1 |
Abcam |
ab126783; RRID: AB_11127730 |
ABCG2 |
Abcam |
ab108312; RRID: AB_10861951 |
LMO7 |
Abcam |
ab224113 |
MDR1 |
Cell Signaling Technology Inc |
13342; RRID: AB_2631176 |
NANOG |
Cell Signaling Technology Inc |
4903; RRID: AB_10559205 |
MPRIP |
Cell Signaling Technology Inc |
14396; RRID: AB_2798472 |
YAP |
Cell Signaling Technology Inc |
14074; RRID: AB_2650491 |
pS397YAP |
Cell Signaling Technology Inc |
13619; RRID: AB_2650554 |
pS109YAP |
Cell Signaling Technology Inc |
46931; RRID: AB_2799315 |
KLF4 |
Cell Signaling Technology Inc |
4038; RRID: AB_2265207 |
FAP |
Santa Cruz Biotechnology |
sc-65398; RRID: AB_831316 |
CD45 |
BD Biosciences |
clone 30-F11; Cat# 557659, RRID: AB_396774 |
CD86 |
BD Biosciences |
clone GL1; Cat# 560956, RRID: AB_10563076 |
CD206 |
BD Biosciences |
clone MR5D3; Cat# 564668, RRID: AB_2738882 |
F4/80 |
BD Biosciences |
clone T45-2342; 565410, RRID: AB_2687527 |
|
Bacterial and virus strains |
|
LV-GV249/FAP/GFP |
GeneChem Co., Ltd |
N/A |
LV-GV249/GFP |
GeneChem Co., Ltd |
N/A |
|
Biological samples |
|
Paraffin tissue section of CRC patients |
Peking University Cancer Hospital & Institute |
N/A |
|
Critical commercial assays |
|
CCK-8 |
Dojido |
CK04 |
Bio-Rad SureBeads™ Magnetic Beads Kit |
Bio-Rad |
1614916 |
RhoA activation assay kit |
Cytoskeleton |
BK036 |
murine tumor dissociation kit |
Miltenyi Biotec |
130-095-929 |
Proteome Profiler Human Cytokine Array kit |
R&D Systems, Inc. |
ARY005B |
|
Experimental models: Cell lines |
|
HCT116 |
ATCC |
CCL-247 |
HCT8 |
ATCC |
CCL-244 |
LS174T |
ATCC |
CL-188 |
|
Experimental models: mouse |
|
BALB/c-nu mice |
Beijing HFK Bio-technology Co. Ltd |
N/A |
|
Oligonucleotides |
|
GAPDH forward 5′- TGCACCACCAACTGCTTAGC-3′ |
Invitrogen |
N/A |
GAPDH reverse 5′- GGCATGGACTGTGGTCATGAG-3′¢ |
Invitrogen |
N/A |
FAP forward 5′- GGAAGTGCCTGTTCCAGCAATG -3′¢ |
Invitrogen |
N/A |
FAP reverse 5′- TGTCTGCCAGTCTTCCCTGAAG -3′¢ |
Invitrogen |
N/A |
BMI1 forward 5′- AGCAGCAATGACTGTGATGC-3′ |
Invitrogen |
N/A |
BMI1 reverse 5′-CAGTCTCAGGTATCAACCAG-3′ |
Invitrogen |
N/A |
ABCG2 forward 5′-CCTGGTGCTCCATGAGGAGAC-3′ |
Invitrogen |
N/A |
ABCG2 reverse 5′-CAGACTCTGACCTTTTGCCAGG-3′ |
Invitrogen |
N/A |
SOX2 forward 5′-ACATGAACGGCTGGAGCAAC-3′ |
Invitrogen |
N/A |
SOX2 reverse 5′-AGGAAGAGGTAACCACAGGG-3′ |
Invitrogen |
N/A |
OCT4 forward 5′-GACAACAATGAAAATCTTCAGGAGA-3′ |
Invitrogen |
N/A |
OCT4 reverse 5′-CTGGCGCCGGTTACAGAACCA-3′ |
Invitrogen |
N/A |
NANOG forward 5′-TGCCTCACACGGAGACTGTC-3′ |
Invitrogen |
N/A |
NANOG reverse 5′-TGCTATTCTTCGGCCAGTTG-3′ |
Invitrogen |
N/A |
CTNNB forward 5′-TGATGGAGTTGGACATGGCC-3′ |
Invitrogen |
N/A |
CTNNB reverse 5′-CTCATACAGGACTTGGGAGG-3′ |
Invitrogen |
N/A |
KLF4 forward 5′-AAGCCAAAGAGGGGAAGAC-3′ |
Invitrogen |
N/A |
KLF4 reverse 5′-CATCTGAGCGGGCGAATTTC-3′ |
Invitrogen |
N/A |
MDR-1 forward 5′-GCCTGGCAGCTGGAAGACAAATAC-3′ |
Invitrogen |
N/A |
MDR-1 reverse 5′-ATGGCCAAAATCACAAGGGTTAGC-3′ |
Invitrogen |
N/A |
ABCG2 forward 5′-GGAGGCCTTGGGATACTTTGAA-3′ |
Invitrogen |
N/A |
ABCG2 reverse 5′-GAGCTATAGAGGCCTGGGGATTAC-3′ |
Invitrogen |
N/A |
ALDH1 forward 5′-CGGGAAAAGCAATCTGAAGAGGG-3′ |
Invitrogen |
N/A |
ALDH1 reverse 5′-GATGCGGCTATACAACACTGGC-3′ |
Invitrogen |
N/A |
ALCAM forward 5′-TCCAGAACACGATGAGGCAGAC-3′ |
Invitrogen |
N/A |
ALCAM reverse 5′-GTAGACGACACCAGCAACAAGG-3′ |
Invitrogen |
N/A |
EPHB2 forward 5′-CGCCATCTATGTCTTCCAGGTG-3′ |
Invitrogen |
N/A |
EPHB2 reverse 5′-GATGAGTGGCAACTTCTCCTGG-3′ |
Invitrogen |
N/A |
siFAP5′-GAACAATATCCTAGAACAA dTdT -3′ |
RiboBio Co. Ltd. |
N/A |
siMPRIP5′-GACGGTTCTTCATCCTTTA dTdT -3′ |
RiboBio Co. Ltd. |
N/A |
|
Software and algorithms |
|
GraphPad Prism 6.0 software |
GraphPad Prism Software Inc. |
https://www.graphpad.com/ |